Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma

Area of Science:

• Ophthalmology
• Cardiovascular Biology

Background:

• Primary open angle glaucoma (POAG) is a leading cause of irreversible blindness.
• Elevated intraocular pressure (IOP) is a primary risk factor for POAG, but progression can occur even with normal or normalized IOP.
• Endothelin-1 (ET-1) is a potent vasoconstrictor with implications in cardiovascular and ocular diseases.

Purpose of the Study:

• To investigate plasma endothelin-1 (ET-1) levels in POAG patients with visual field progression despite normal or normalized IOP.
• To compare ET-1 levels between POAG patients with progressive visual fields and those with stable visual fields.

Main Methods:

• Retrospective study comparing 16 POAG patients with progressive visual fields and 15 with stable visual fields.
• Plasma ET-1 levels were measured from venous blood samples after a 30-minute rest period.
• Analysis of covariance (ANCOVA) was used to compare ET-1 levels, adjusting for age, sex, and mean arterial blood pressure.

Main Results:

• Plasma ET-1 levels were significantly higher in the progressive POAG group (3.47 ± 0.75 pg/ml) compared to the stable POAG group (2.59 ± 0.54 pg/ml).
• The difference in ET-1 levels was statistically significant (p = 0.0007).

Conclusions:

• POAG patients experiencing visual field progression with normal or normalized IOP exhibit increased plasma ET-1 levels.
• Further research is needed to determine if elevated ET-1 is a consequence of glaucomatous damage or a contributing factor to its progression.